Clinical Updates & Insights

Our clinical updates provide you with timely information about Memorial Sloan Kettering’s new treatment approaches, key clinical trials, and innovations in detecting and treating many cancers.

Stay Informed

Get the latest information on MSK’s cancer treatments and research sent straight to your inbox with our monthly clinical updates e-newsletter OncoNotes.

Newsletter Sign Up Manage Preferences
MSK breast cancer specialist Diana Lake talks to a patient about clinical trials
Find a Clinical Trial
Pictured: Gregory J. Riely
Refer a Patient

171 Clinical Updates found

Clinical Update

Nasal Cavity Cancer: Radiation Is a Valid Option for Patients Refusing Surgery

Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.

  • Friday, June 7, 2019

Clinical Update

Tackling Lymphedema: New Insights from MSK’s Dedicated Lab

New insights into the pathophysiology of lymphedema are providing targets for future treatment interventions to cure and prevent the disease, according to our recent research.

  • Friday, June 7, 2019

Clinical Update

Less Is Better: Promising Results for Reduced-Dose Radiation Therapy in High-Risk Pediatric Neuroblastoma

Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial.

  • Monday, May 13, 2019

Clinical Update

Less Risk of Femoral Fracture with Intensity-Modulated Radiation Therapy for Thigh and Groin Sarcoma

Intensity-modulated radiation therapy (IMRT) confers a lower risk of femoral fracture in patients with primary soft tissue sarcoma of the thigh or groin, despite a higher dose of radiation to the target volume compared to conventional radiation.

  • Monday, May 13, 2019

Clinical Update

Surgery Is Critical in Advanced Testicular Cancer

Resection of all residual disease after salvage chemotherapy offers the best chance for a cure for patients with refractory or relapsed advanced testicular cancer, according to the results of our recent retrospective study.

  • Friday, April 5, 2019

Clinical Update

Deep Learning with MRI-Radiomics Improves Survival Prediction in Glioblastoma

Incorporating radiomics with methyl guanine methyl transferase (MGMT) status can more accurately stratify glioblastoma patients into groups with different survival risks compared to using either prediction tool in isolation.

  • Thursday, April 4, 2019

Clinical Update

Video: Expanding Organ Preservation Surgery in Esophageal Cancer

Daniela Molena, MD, Director, Esophageal Surgery Program, talks on expanding organ preservation surgery in esophageal cancer and the quest to pinpoint the elusive sentinel node in these patients.

  • Wednesday, March 6, 2019

Clinical Update

The Most Recent Staging System for Thyroid Cancer Downgrades Almost One-Third of Cases

The newest edition of the thyroid cancer staging system has increased the age at diagnosis as a prognostic factor by a decade.

  • Friday, March 1, 2019

Clinical Update

Watch-and-Wait Strategy Results in Rectal Preservation for Select Rectal Cancer Patients

A carefully monitored, multidisciplinary watch-and-wait strategy can result in excellent rectal preservation and pelvic tumor control for a large majority of select patients with rectal cancer who show a clinical complete response after neoadjuvant therapy.

  • Friday, March 1, 2019

Clinical Update

Case Study: Pituitary Carcinoma Response to Immunotherapy

Treating pituitary tumors with combination immunotherapy may be an effective treatment strategy, especially for tumors that are resistant to temozolomide.

  • Friday, February 8, 2019